AUTHOR=Garg Mandeep , Prabhakar Nidhi , Devkota Shritik , Dhooria Sahajal , Debi Uma , Dua Ashish , Singh Tarvinder , Malarakunte Muniraju , Bhatia Harsimran , Sandhu Manavjit Singh 

TITLE=Chest CT Findings at Six Months Following COVID-19 ARDS – Correlation With the mMRC Dyspnea Scale and Pulmonary Function Tests

JOURNAL=British Journal of Biomedical Science

VOLUME=81

YEAR=2024

URL=https://www.frontierspartnerships.org/journals/british-journal-of-biomedical-science/articles/10.3389/bjbs.2024.12871

DOI=10.3389/bjbs.2024.12871

ISSN=2474-0896

ABSTRACT=<p><bold>Background:</bold> Many survivors of severe COVID-19 pneumonia experience lingering respiratory issues. There is limited research on follow-up chest imaging findings in patients with COVID-19 ARDS, particularly in relation to their mMRC dyspnea scores and pulmonary function tests (PFTs). This study addresses this gap by investigating the clinical characteristics, mMRC dyspnea scores, PFTs, and chest CT findings of COVID-19 ARDS patients at the 6 months post-recovery. By analyzing these variables together, we aim to gain a better understanding of the long-term health consequences of COVID-19 ARDS.</p><p><bold>Methods:</bold> This prospective observational study included 56 subjects with COVID-19 ARDS with dyspnea at the six-month follow-up visits. These patients were evaluated by chest CT, mMRC dyspnea scale, and PFT. The CT severity score was calculated individually for each of the four major imaging findings - ground glass opacities (GGOs), parenchymal/atelectatic bands, reticulations/septal thickening, and consolidation - using a modified CT severity scoring system. Statistics were carried out to find any association between individual CT chest findings and the mMRC dyspnea scale and forced vital capacity (FVC). p values &lt; 0.05 were considered statistically significant.</p><p><bold>Results:</bold> Our study population had a mean age of 55.86 ± 9.60 years, with 44 (78.6%) being men. Grades 1, 2, 3, and 4 on the mMRC dyspnea scale were seen in 57.1%, 30.4%, 10.7%, and 1.8% of patients respectively. Common CT findings observed were GGOs (94.6%), reticulations/septal thickening (96.4%), parenchymal/atelectatic bands (92.8%), and consolidation (14.3%). The mean modified CT severity scores for GGOs, reticulations/septal thickening, parenchymal/atelectatic bands, and consolidation were 10.32 ± 5.51 (range: 0–21), 7.66 ± 4.33 (range: 0–19), 4.77 ± 3.03 (range: 0–14) and 0.29 ± 0.91 (range 0–5) respectively. Reticulations/septal thickening (p = 0.0129) and parenchymal/atelectatic bands (p = 0.0453) were associated with an increased mMRC dyspnea scale. Parenchymal/atelectatic bands were also associated with abnormal FVC (&lt;80%) (p = 0.0233).</p><p><bold>Conclusion:</bold> Six-month follow-up chest CTs of COVID-19 ARDS survivors with persistent respiratory problems showed a statistically significant relationship between increased mMRC dyspnea score and imaging patterns of reticulations/septal thickening and parenchymal/atelectatic bands; while parenchymal/atelectatic bands also showed a statistically significant correlation with reduced FVC.</p>